Kidney cancer features in young patients
Part of Cancer, Kidney & urinary clinical trials.
This study looks at kidney cancer in patients under 40 to understand how the disease behaves and how it responds to treatment. It may help doctors learn more about kidney cancer in younger people.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are under 40 years old.
- You have been diagnosed with kidney cancer (renal cell carcinoma).
- You are able to receive treatment for your cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at a specific genetic change in kidney tumors in children, teens, and young adults up to age 30. It aims to understand how that change affects patients who are newly diagnosed or whose cancer has come back, and may guide future care.
This research study helps doctors understand inherited kidney cancers and related conditions that run in families. Researchers collect medical information and blood samples to identify genetic causes and improve how these conditions are diagnosed and treated.
This study tests whether closely monitoring small kidney tumors (less than 4 cm) with regular imaging is a safe and effective option for people who cannot or choose not to have immediate treatment. It involves a biopsy at the start to confirm the tumor type.
This trial studies how people with kidney cancer decide to join clinical studies. It looks at trends in participation to help make future studies better.
This study looks at patients with kidney cancer that hasn't spread and is considered high-risk. It uses a registry to learn more about these patients to improve future care.
This study looks at blood or body measures called “biomarkers” to understand how lack of oxygen and body energy changes in clear cell kidney cancer. It compares people with kidney cancer to carefully matched healthy volunteers to see what patterns might help improve understanding or future care.
Hear when a new Clinicopathologic Characters of Renal Cell Carcinoma in Young Patients trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.